ESPE2024 Poster Category 1 Diabetes and Insulin 3 (9 abstracts)
1JPMC, Bandar Seri Bagawan, Brunei Darussalam. 2MOSC, Kochi, India
Background: The alarming increase in the prevalence of obesity in children and adolescents following COVID-19 pandemic has given rise to an upward trend in Type 2 Diabetes.
Aims/Objectives: To determine the prevalence of newly diagnosed Type 2 Diabetes in children and adolescents from the year 2018 to 2022.
Methods: A hospital based retrospective study was conducted in the Paediatric Endocrinology Clinic at a tertiary care Centre in Kerala, South India, to determine the prevalence of new onset Type 2 Diabetes among children attending Paediatric Endocrinology Clinic during a 4-year period from 1st January 2018 through 1st August 2022. Demographic, anthropometrics, clinical data and laboratory, and outcomes were obtained. All the data was interpreted using descriptive and inferential statistics on R software and SPSS version 21.0.
Results: The prevalence of Type 2 Diabetes has increased by 66.66% after the COVID-19 pandemic onset. The mean age of 1st presentation has decreased from 14.5 years to 11.9±2 years following COVID-19, with males being affected more than females. Increased screen time and reduced physical activity were present in 90 % of the children. All of them had a positive family history of Type 2 Diabetes. Children diagnosed to have Type 2 Diabetes following COVID-19 had an average BMI of 24.82±3, with abdominal circumference above 90th percentile for all. All the diagnosed cases were started on Metformin. However, 30% of children presented with mild to moderate DKA requiring insulin in addition to OHA for glycaemic control.
Discussion: COVID-19 lockdown disrupted the everyday routine of children and adolescents in a significant way. Increase in the screen time and lack of adequate physical activity has led to an increase in childhood obesity and thereby Type 2 Diabetes presenting at a much younger age than before COVID-19. The number of children with Type 2 Diabetes presenting with cardiometabolic complications like dyslipidaemia and hypertension at a younger age was also high. Around 40% of children above 10 years presented as metabolic syndrome. Children admitted with new onset Type 2 Diabetes after the COVID-19 pandemic were significantly more likely to present with DKA.
Conclusion: Following COVID-19 pandemic, the sedentary lifestyle and associated childhood obesity has led to a significant increase in Type 2 Diabetes cases with a greater risk of DKA. This shows a change in Paediatric diabetic trend. Further multicentric studies must be done to unveil the extend of COVID-19 pandemic impact on Paediatric Type 2 Diabetes.